If you accidentally inject more Toujeo than prescribed, monitor your blood sugar closely and eat a carbohydrate-containing snack if levels drop
According to the Summary of Product Characteristics (SmPC), the most commonly reported adverse effects include: Nausea and vomiting (very common) particularly during dose escalation Diarrhoea or constipation (very common) affecting bowel regularity Abdominal pain and discomfort (common) often mild to moderate Reduced appetite (very common) contributing to weight loss Dyspepsia (common) indigestion or heartburn Injection site reactions (common) such as redness or irritation Fatigue (common) tiredness or lack of energy These gastrointestinal symptoms typically diminish over time as the body adjusts to the medication
Most community protocols start cagrilintide at 0.25 mg/week once retatrutide is established, then step up every 4 weeks to 0.5, 1.0, 1.7, and 2.4 mg/week
FDA-approved GLP-1 programs, personalized plans, and a physician who follows your progress every step of the way
Combined with mindful eating, exercise, adequate sleep, and avoiding sugary, ultra-processed foods, these strategies can help you maintain steady GLP-1 levels and support sustainable weight loss
Consult a dermatologist Average online dermatologist response time from AprilJune 2026: 14.4 hours What is tretinoin (Retin-A) cream